![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » GSK’s Witty to Step Down in 2017
GSK’s Witty to Step Down in 2017
March 23, 2016
After serving at GlaxoSmithKline for 32 years — 10 as CEO — Andrew Witty will retire on March 31, 2017.
A formal search for Witty’s successor is under way, and both external and internal candidates will be considered.
Upcoming Events
-
21Oct